Visits: 13594, Avg visit time (secs): 214,86 Back to Index
| Page | Hits | Percent |
|---|---|---|
| 6392 | 47,02% | |
| /programmes.html | 1343 | 9,88% |
| /home.html | 447 | 3,29% |
| /msd/albert-renold/efsd-msd-arenold.html | 301 | 2,21% |
| /novo-t2/efsd-novo-t2-rfa08.html | 256 | 1,88% |
| /lilly/programme/efsd-lilly-cds-fellowship10.html | 222 | 1,63% |
| /lilly/programme/efsd-lilly-cds-fellowship08.htm | 201 | 1,48% |
| /pfizer/efsd-pfizer-rfa09.html | 197 | 1,45% |
| /gsk/efsd-gsk-rfa08.html | 186 | 1,37% |
| /lilly/fellowships/efsd-lilly-fship09.html | 161 | 1,18% |
| /novo_2010/novo_2010_ rfa.html | 158 | 1,16% |
| Page | Hits | Percent |
|---|---|---|
| /exit.htm | 7394 | 54,39% |
| /pfizer/efsd-pfizer-rfa10.html | 459 | 3,38% |
| /programmes.html | 458 | 3,37% |
| /home.html | 378 | 2,78% |
| /pfizer/efsd-pfizer-rfa09.html | 309 | 2,27% |
| /msd/albert-renold/efsd-msd-arenold.html | 301 | 2,21% |
| /recipients.html | 262 | 1,93% |
| /pfizer2008rfa.html | 215 | 1,58% |
| / | 201 | 1,48% |
| /lilly/programme/efsd-cds-lilly-rfa09.html | 158 | 1,16% |
| /gsk/efsd-gsk-rfa08.html | 132 | 0,97% |